Index RUT
P/E -
EPS (ttm) -3.97
Insider Own 5.94%
Shs Outstand 94.67M
Perf Week -8.64%
Market Cap 91.13M
Forward P/E 191.86
EPS next Y 0.01
Insider Trans -0.18%
Shs Float 89.35M
Perf Month 13.23%
Income -331.94M
PEG -
EPS next Q -0.03
Inst Own 49.03%
Short Float 12.01%
Perf Quarter -13.58%
Sales 152.07M
P/S 0.60
EPS this Y -121.82%
Inst Trans 11.54%
Short Ratio 9.54
Perf Half Y -63.52%
Book/sh 1.46
P/B 0.66
EPS next Y 104.17%
ROA -94.80%
Short Interest 10.73M
Perf Year -84.68%
Cash/sh 0.77
P/C 1.24
EPS next 5Y 25.00%
ROE -182.52%
52W Range 0.77 - 8.01
Perf YTD -10.35%
Dividend Est. -
P/FCF 1.86
EPS past 5Y -
ROI -186.50%
52W High -88.02%
Beta 0.97
Dividend TTM -
Quick Ratio 1.43
Sales past 5Y -9.66%
Gross Margin 64.04%
52W Low 24.58%
ATR (14) 0.08
Dividend Ex-Date -
Current Ratio 1.83
EPS Y/Y TTM -272.27%
Oper. Margin 10.79%
RSI (14) 48.15
Volatility 6.67% 8.28%
Employees 53
Debt/Eq 0.30
Sales Y/Y TTM -2.66%
Profit Margin -218.28%
Recom 1.00
Target Price 3.00
Option/Short Yes / Yes
LT Debt/Eq 0.29
EPS Q/Q -145.92%
Payout 0.00%
Rel Volume 0.83
Prev Close 0.99
Sales Surprise -3.39%
EPS Surprise -
Sales Q/Q -34.49%
Earnings Mar 11 AMC
Avg Volume 1.13M
Price 0.96
SMA20 -2.98%
SMA50 6.88%
SMA200 -60.46%
Trades
Volume 930,379
Change -3.10%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-07-22 Initiated
Lake Street
Buy
$7
Nov-30-18 Downgrade
Mizuho
Buy → Neutral
Mar-12-24 11:11AM
08:31AM
05:49AM
(Thomson Reuters StreetEvents)
Mar-11-24 04:26PM
(Associated Press Finance)
04:01PM
05:07PM
Loading…
Mar-04-24 05:07PM
Feb-29-24 04:05PM
Feb-28-24 10:15AM
Feb-26-24 07:57PM
Feb-23-24 11:30AM
05:45AM
Feb-22-24 12:35PM
Feb-19-24 12:39PM
Feb-16-24 12:41PM
11:28AM
05:45AM
Loading…
Feb-13-24 05:45AM
Feb-12-24 10:30AM
Feb-09-24 02:51PM
Feb-05-24 03:56PM
10:24AM
10:08AM
Feb-02-24 12:32PM
12:19PM
Jan-29-24 12:30PM
Jan-26-24 09:15AM
Jan-24-24 06:54PM
10:15AM
Jan-22-24 03:42PM
Jan-19-24 09:36AM
Jan-17-24 10:15AM
09:35AM
Loading…
09:35AM
Jan-15-24 03:29PM
Jan-10-24 10:45AM
Jan-08-24 12:14PM
Jan-05-24 06:56PM
Jan-04-24 09:46AM
Jan-03-24 08:59AM
Dec-25-23 02:06PM
Nov-14-23 08:00AM
Nov-10-23 01:11PM
Nov-09-23 08:49AM
(Thomson Reuters StreetEvents) -43.19%
Nov-08-23 06:46PM
04:30PM
(Associated Press Finance)
04:01PM
Nov-02-23 12:06PM
Oct-06-23 04:30PM
Sep-22-23 08:38AM
Sep-14-23 01:12PM
Aug-28-23 06:30PM
Aug-25-23 04:05PM
Aug-23-23 08:48AM
Aug-08-23 04:45PM
09:15AM
Aug-06-23 08:05AM
07:14AM
Aug-03-23 04:29PM
(Associated Press Finance)
04:04PM
Jul-31-23 07:27PM
Jul-27-23 04:01PM
Jul-24-23 08:30AM
Jul-19-23 07:38AM
Jul-07-23 09:16AM
Jun-26-23 07:00AM
Jun-16-23 06:30AM
May-26-23 12:06PM
May-10-23 06:12AM
01:34AM
(Thomson Reuters StreetEvents)
May-09-23 07:28AM
07:15AM
06:02AM
May-05-23 08:00AM
May-04-23 10:54AM
06:10AM
Apr-27-23 09:00AM
Apr-25-23 01:03PM
06:00AM
Apr-24-23 09:00AM
09:00AM
Apr-17-23 06:43AM
Apr-10-23 09:00AM
Apr-07-23 04:00PM
Mar-29-23 10:13AM
Mar-27-23 09:00AM
Mar-14-23 09:00AM
Mar-10-23 02:37AM
Mar-09-23 12:19PM
(Thomson Reuters StreetEvents) +11.74%
Mar-08-23 11:43PM
(Thomson Reuters StreetEvents)
04:01PM
Mar-06-23 09:00AM
06:00AM
Mar-03-23 09:00AM
Mar-02-23 08:34AM
Mar-01-23 12:41PM
Feb-23-23 07:14AM
Feb-21-23 07:00AM
Feb-20-23 09:00AM
Feb-16-23 08:00AM
Feb-14-23 09:30AM
Feb-13-23 10:31AM
Feb-09-23 06:25AM
Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Tyree James L Director Mar 14 '24 Sale 1.12 10,251 11,463 188,251 Mar 15 08:01 PM Schlessinger Sam SVP, General Counsel Feb 21 '24 Option Exercise 0.00 17,151 0 109,384 Feb 23 05:32 PM Patel Ajay SVP and CFO Feb 21 '24 Option Exercise 0.00 17,151 0 141,760 Feb 23 05:30 PM Schwichtenberg Paul SVP, CCO Feb 21 '24 Option Exercise 0.00 17,151 0 112,430 Feb 23 05:31 PM Schlessinger Sam SVP, General Counsel Feb 11 '24 Option Exercise 0.00 18,939 0 98,785 Feb 13 07:02 PM Patel Ajay SVP and CFO Feb 11 '24 Option Exercise 0.00 47,348 0 140,991 Feb 13 07:00 PM Schwichtenberg Paul See Remarks Feb 11 '24 Option Exercise 0.00 47,348 0 111,661 Feb 13 07:01 PM Schlessinger Sam SVP, General Counsel Oct 01 '23 Option Exercise 0.00 19,404 0 88,442 Oct 03 07:27 PM Peisert Daniel A. President & CEO Sep 12 '23 Sale 2.97 31,121 92,432 324,939 Sep 13 08:15 PM Peisert Daniel A. President & CEO Sep 11 '23 Sale 3.04 127,281 386,972 356,060 Sep 13 08:15 PM Schwichtenberg Paul SVP and CFO Sep 11 '23 Sale 3.07 104,980 322,593 64,313 Sep 13 08:16 PM Patel Ajay SVP and CAO Sep 11 '23 Sale 3.04 64,313 195,794 93,643 Sep 13 08:17 PM Schlessinger Sam SVP, General Counsel Sep 11 '23 Sale 3.04 45,236 137,441 69,038 Sep 13 08:18 PM MCKEE WILLIAM Director Aug 14 '23 Sale 3.14 22,000 69,045 238,780 Aug 15 06:00 PM Schlessinger Sam SVP, General Counsel Aug 05 '23 Option Exercise 0.00 7,135 0 117,434 Aug 08 07:00 PM Mason Heather L Director May 19 '23 Sale 7.30 89,286 652,011 187,650 May 22 08:00 PM Patel Ajay SVP and CAO May 12 '23 Option Exercise 0.00 238,017 0 314,819 May 15 08:58 PM Schlessinger Sam SVP, General Counsel May 12 '23 Option Exercise 0.00 238,017 0 267,162 May 15 08:58 PM Peisert Daniel A. President and CEO May 12 '23 Option Exercise 0.00 552,067 0 797,066 May 15 08:57 PM Schwichtenberg Paul SVP and CFO May 12 '23 Option Exercise 0.00 238,017 0 326,156 May 15 08:58 PM Tyree James L Director May 05 '23 Sale 6.00 43,143 258,767 167,308 May 05 09:10 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite